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Background: Early diagnosis and appropriate antibiotic treatment can significantly reduce mortality of nosocomial
bacterial meningitis. However, it is a challenge for clinicians to make an accurate and rapid diagnosis of bacterial
meningitis. This study aimed at determining whether combined biomarkers can provide a useful tool for the
diagnosis of bacterial meningitis.
Methods: A retrospective study was carried out. Cerebrospinal fluid (CSF) levels of decoy receptor 3 (DcR3) and
soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) were detected by enzyme-linked immunosorbent
assay (ELISA).
Results: The patients with bacterial meningitis had significantly elevated levels of the above mentioned biomarkers.
The two biomarkers were all risk factors with bacterial meningitis. The biomarkers were constructed into a “bioscore”.
The discriminative performance of the bioscore was better than that of each biomarker, with an area under the
receiver operating characteristic (ROC) curve (AUC) of 0.842 (95% confidence intervals (CI) 0.770–0.914; p< 0.001).
Conclusions: Combined measurement of CSF DcR3 and sTREM-1 concentrations improved the prediction
of nosocomial bacterial meningitis. The combined strategy is of interest and the validation of that improvement
needs further studies.
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Nosocomial bacterial meningitis is a significant problem
among hospitalized patients, which threatens patients’
lives, extends their stay in hospital and increases the med-
ical costs, sometimes even results in doctor-patient con-
flicts. Despite emergence of antibiotics and improvement
of clinical techniques, bacterial meningitis continues to be
a significant cause of morbidity and mortality [1,2]. Early
effective antibiotic therapy is associated with better out-
comes [3,4] and the choice of appropriate antibiotics is* Correspondence: lixianma1955@163.com
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cific pathogen.
However, the diagnosis of this disease remains a chal-
lenge. Firstly, the clinical signs of fever, headache, neck
stiffness and mental status alteration are not specific [1,2].
Secondly, laboratory tests are also not specific enough.
Cerebrospinal fluid (CSF) culture is specific but lacks sen-
sitivity, especially with previous use of antibiotics [2]. In
addition, the unnecessary use of antibiotics increases
the chance of being infected by multidrug-resistant bac-
teria [4]. Based on the above reasons, the development
of new indicators for the rapid diagnosis of bacterial
meningitis is desirable.
Decoy receptor 3 (DcR3), a soluble decoy receptor in
the TNF receptor (TNFR) family, is capable of inhibitings is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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three members of the TNF superfamily: Fas ligand (FasL)
[5], LIGHT [receptor homologous to lymphotoxins ex-
hibits inducible expression, competes with herpes simplex
virus (HSV) glycoprotein D for HVEM and is expressed
by T lymphocytes] [6] and TNF-like molecule 1A (TL1A)
[7]. In addition, DcR3 can be a new potential biomarker
for inflammatory disease, autoimmune diseases and can-
cer [8-12]. Our previous study has proved that levels of
DcR3 are significantly elevated in patients with bacterial
meningitis and it may act as a useful biomarker of bacter-
ial meningitis [13].
The triggering receptor expressed on myeloid cells-1
(TREM-1) is a recently described receptor on the surfaces
of monocytes and neutrophils [14]. Many previously pub-
lished studies have indicated that the soluble form of
TREM-1, called sTREM-1, is a useful indicator for bac-
terial infection [15-18]. Indeed, several studies have sug-
gested that sTREM-1 is valuable for the diagnosis of
bacterial meningitis [16,17] before a positive result of
CSF culture. These data show the individual predictive
value of these two biomarkers. Combination of several
biomarkers can improve diagnostic value in various dis-
eases or conditions: such as sepsis [19], liver fibrosis [20],
community-acquired pneumonia [21] and severe malaria
[22]. However, the strategy of combined DcR3 and sTREM-
1 has not yet been validated for bacterial meningitis.
The aim of this study was to evaluate the combined
diagnostic value of DcR3 and sTREM-1.
Materials and methods
Patients and data collection
Diagnosis of bacterial meningitis was based on a positive
result of CSF culture. Nosocomial meningitis was defined
as negative bacterial infection when the patient was admit-
ted to the hospital, clinical evidence of an infection was
found after 48 hours on admission or within one month
after discharge from the hospital where the patient had re-
ceived an invasive neurosurgical procedure. Otherwise,
the patient was considered to have community-acquired
meningitis [23,24]. External ventricular drain-related men-
ingitis was diagnosed with bacterial infection being found
within 7 days of external ventricular drain removal [25].
One hundred and twenty-three patients in this study
were enrolled in Qilu Hospital of Shandong University
in China within November 2012 and October 2013. All
patients in this study were categorized into two groups.
Inclusion and exclusion criteria are described more ex-
tensively elsewhere. The mean age (mean ± SD) of 80
patients with bacterial meningitis was 43.75 ± 16.46
years. The area under the receiver operating characteris-
tic (ROC) curve (AUC) of DcR3 was 0.831 [13]. The
biomarkers associated with this study were CSF DcR3
and sTREM-1.This study was approved by Institutional Research Ethics
Committee of Qilu Hospital of Shandong University (No.
KYLL-2012-096). Written informed consents were taken
from patients or clients before registration.
Detection of sTREM-1 and DcR3
The CSF samples were centrifuged and supernatants were
frozen at −80°C until assay. Levels of sTREM-1 and DcR3
in CSF were determined in duplicate by ELISA according
to the kits instructions (Cusabio, Wuhan, China). The
detection limits were 7.8 pg/mL for sTREM-1 and 0.039
ng/mL for DcR3.
Statistical analysis
Descriptive results of sTREM-1 and bioscore were
expressed as median (25th and 75th percentiles) and
Mann–Whitney U-test was used to analyze the continu-
ous data of sTREM-1 and bioscore. ROC curve and
AUC were applied to evaluate the discriminatory power
of each marker and combined CSF markers. The Youden
index (J = max (sensitivity + specificity − 1)) was used to
define the cut-off value. Risk factors related to bacterial
meningitis were explored by multivariate stepwise logistic
regression analysis. Hosmer-Lemeshow goodness-of-fit test
was used for the calibration of logistic regression model.
All analyses were performed with SPSS, version 20.0
and a two-sided p < 0.05 was considered to be statisti-
cally significant.
Results
Demographic characteristics of patients
Among the 123 patients recruited in this study, 80 pa-
tients were diagnosed with bacterial meningitis [13]. In
patients with bacterial meningitis, 6 patients had external
ventricular drain-related meningitis. The levels of CSF
DcR3 were significantly different between the groups of
bacterial meningitis and non-bacterial meningitis. 44 pa-
tients received antibiotic >24 h before CSF sampling,
among them 5 patients with non-bacterial meningitis and
39 patients with bacterial meningitis [13]. Concentrations
of sTREM-1 in the patients with bacterial meningitis
were significantly higher than those with non-bacterial
meningitis (19.017 (0 –60.256) pg/mL vs. 0 (0–0) pg/mL,
p < 0.001).
As shown in Table 1, predisposing conditions were
present in all patients, such as neurosurgery, pneumonia,
CSF leak, etc. All the 80 patients with bacterial meningitis
underwent neurosurgical operation (Tables 1 and 2). The
most frequently isolated microorganism was coagulase-
negative Staphylococci (Table 3). More than half of the
patients (n=44) had intracranial tumor surgery. The con-
ditions necessitating surgical interventions were shown in
Table 2.








Recent Head Injury* 6 (7.50)
CSF Leak 4 (5.00)
Neurosurgical Devices▲ 44 (55.00)
Symptoms and Signs on Presentation
Seizures 6 (7.50)
Headache 57 (71.25)
Neck Stiffness 28 (35.00)
Body Temperature≥ 38°C 63 (78.75)
Triad of Fever, Neck Stiffness, and Change in
Mental Status
10 (12.50)
Positive Blood Culture 1/3 (33.33)☼
All categorical data are expressed as number (%) unless indicated otherwise.
*Recent denotes within one month of the onset of meningitis. CSF:
cerebrospinal fluid. ▲Neurosurgical devices include ventriculostomy,
ventriculoperitoneal shunt, lumbar puncture catheter, spinal cavity shunt
and external ventricular drainage catheter. ☼Data are number/number
evaluated (%).
Table 3 Results of isolated microorganism(s)
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meningitis from non-bacterial meningitis
ROC curve and AUC were performed to determine the
discriminative accuracy of CSF sTREM-1 and DcR3.
Combined with the published data, CSF DcR3 yielded a
higher discriminative value with an AUC of 0.831 [13].Table 2 Neurosurgical interventions
Type of surgery Positive culture
(n=80)
Intracranial Tumor Operation 44
Evacuation of Intracranial Haematoma 6
Repair of Cranial Defect 6
Ventriculoperitoneal Shunt 4
Repair of CSF Rhinorrhea 1
Suboccipital Decompression 4
Ventriculostomy 3
Decompression of Trigeminal Neuralgia 3
Ventricular External Drainage 3
Aneurysm Plus Ligation 1
Aneurysm Embolization 3
Arachnoid Cyst Excision 1
Posterior Fossa Decompression and Spinal
Cavity Shunt
1The AUC of sTREM-1 for predicting bacterial meningi-
tis was 0.756 (95% confidence intervals (CI) 0.673-0.839;
p < 0.001, Figure 1). A cut-off value of 11.515 pg/mL for
sTREM-1 had a sensitivity of 60.00% (95 CI 48.42% –
70.61%), a specificity of 88.37% (95% CI 74.12% –
95.64%), a positive likelihood ratio (PLR) of 5.16 (95%
CI 2.22-11.99), a negative likelihood ratio (NLR) of 0.45
(95% CI 0.34-0.60), a positive predictive value (PPV) of
90.57% (95% CI 78.58%-96.47%) and a negative predict-
ive value (NPV) of 54.29% (95% CI 42.01%-66.09%).
Comparison of DcR3 and sTREM-1 with other markers in
predicting bacterial meningitis
As shown in Table 4, CSF leucocyte count yielded the
best discriminative value, with an AUC of 0.928, a sensi-
tivity of 88.75% and a specificity of 90.70%. Multivariate
stepwise logistic regression was applied to evaluate the
independent predictors for bacterial meningitis. From
univariate analysis, the following 6 variables: CSF leuco-
cyte count, glucose, protein, lactate, DcR3 and sTREM-1
were associated with bacterial meningitis (Table 5). All
the six markers were taken into a multivariate stepwise
logistic regression model. The result showed that only
sTREM-1 and DcR3 were the independently risk factors
with bacterial meningitis (odds ratio (OR) = 3.325, 95%
CI = 1.185–9.334, p = 0.023 for DcR3; OR = 1.059, 95%
CI = 1.015–1.106, p = 0.008 for sTREM-1; Table 6).
Combination of DcR3 and sTREM-1 to predict bacterial
meningitis
In order to determine whether combined detection of the
markers mentioned above could improve diagnostic ac-
curacy, the biomarkers were combined into a “bioscore”.
For each biomarker, individual data were scored as 1 or 0.
If the data were higher than the critical value, the scores
Figure 1 Receiver operating characteristic (ROC) curves of DcR3 and sTREM-1 for the diagnosis of bacterial meningitis. Areas under the
ROC curve (AUC) are presented with 95% confidence intervals (CI). The AUC of DcR3 has been published previously [13]. In order to compare the
AUC of sTREM-1 with that of DcR3, the figure of DcR3 is presented here. DcR3: 0.831(95% CI 0.752–0.911); sTREM-1: 0.756 (95% CI 0.673-0.839).
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off point, the scores were recorded as 0. The scores con-
stituted the cumulative bioscore, which ranged between
0 and 2.
The biomarker score was significantly elevated for
patients with bacterial meningitis (2 (1–2) vs. 0 (0 –1),
p < 0.001). ROC curve was constructed as above for the
bioscore. The AUC for bioscore was 0.842 (95% CI 0.770–
0.914; p< 0.001; Figure 2). When the bioscore was entered
into the multivariate stepwise logistic regression model,
the bioscore was also proved to be a significant factor
for bacterial meningitis (OR, 7.007, 95% CI 3.576–
13.730; p< 0.001, Table 6).
The possibility of being infected by bacteria grew with
the increasing bioscore. The rate of bacterial meningitis
ranged from 28.89% for a bioscore of 0 to 95.65% for a
bioscore of 2. According to the bioscore, the patients
were divided into three groups. 67 of 78 patients (85.90%)
with a bioscore of 1 or 2 were diagnosed with bacterial
meningitis (Figure 3).Table 4 Diagnostic performance of DcR3, sTREM-1




Sensitivity (%) Speificity (%)
DcR3 0.831 78.75 81.40
sTREM-1 0.756 60.00 88.37
Leucocyte Count 0.928 88.75 90.70
Glucose 0.696 65.00 67.44
Protein 0.664 43.75 86.05
Lactate 0.717 62.50 74.42
The performance of DcR3 and other CSF markers has been published
previously [13]. In order to compare the diagnostic performance of the two
biomarker with that of other CSF markers, the data of DcR3 and CSF markers
are presented here. ROC: receiver operating characteristic.Discussion
Combination of several markers has been found to
improve predictive value in various disorders [19-22].
In this study, we combined the markers of DcR3 and
sTREM-1 into a simple score, named as “bioscore”,
which was proved to be a useful predictor for the diag-
nosis of bacterial meningitis. Furthermore, compared
with the individual marker of DcR3 or sTREM-1, the
bioscore was found to be a better predictor of bacterial
meningitis.
Except its neutralizing effects on FasL, LIGHT, and
TL1A, DcR3 also acts as a pleiotropic effector which can
regulate cellular function via “non-decoy” activities [9].
In addition, DcR3 may have pro-inflammatory functions
[26,27]. In ARDS patients, higher plasma DcR3 levels
are associated with multiple-organ dysfunction, longer
duration of ICU stay and ventilator dependence. Serum
DcR3 levels in non-survivors are higher than those in
survivors regardless of the APACHE II scores. Therefore,
DcR3 appears to possess the potential to serve as both a
diagnostic and a prognostic marker of ARDS [28].
Moreover, levels of DcR3 are elevated in patients withTable 5 Univariate analysis for diagnosing bacterial
meningitis
Variable Coefficient SE Wald df p value OR (95% CI)
DcR3 2.073 0.528 15.401 1 <0.001 7.949 (2.823-22.385)
sTREM-1 0.071 0.020 11.871 1 0.001 1.073 (1.031-1.117)
Leucocyte
Count
0.003 0.001 13.690 1 <0.001 1.003 (1.001-1.004)
Glucose −0.428 0.151 8.013 1 0.005 0.652 (0.485-0.877)
Protein, 0.673 0.264 6.528 1 0.011 1.961 (1.170-3.286)
Lactate 0.375 0.117 10.355 1 0.001 1.455 (1.158-1.829)
SE= standard error; df= degrees of freedom; OR= odds ratio.
Table 6 Multiple logistic regression analysis of risk factors used for diagnosing bacterial meningitis
Hosmer-Lemeshow test
Variable Coefficient SE Wald df p value OR (95% CI) Chi Square df p value
Model 1●
DcR3 1.202 0.527 5.206 1 0.023 3.325 (1.185-9.334) 4.060 8 0.852
sTREM-1 0.058 0.022 6.943 1 0.008 1.059 (1.015-1.106)
Model 2☼
Biscore 1.947 0.343 32.180 1 <0.001 7.007 (3.576-13.730) 0.079 1 0.779
SE= standard error; df= degrees of freedom; OR= odds ratio.
Model 1: each biomarker is entered into the model.
Model 2: biomarkers are combined into the bioscore that is then entered into the model.
●Pseudo R2 (Cox and Snell) 0.326.
☼Pseudo R2 (Cox and Snell) 0.337.
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of sepsis. DcR3 might be considered as a double-edged
sword in sepsis and have the potential to be a novel tar-
get for the treatment of sepsis [10,12]. Our previous
study has showed that detection of CSF DcR3 is useful
for the diagnosis of bacterial meningitis. A cut-off point
of 0.201 ng/mL is established, which has a sensitivity of
78.75% and a specificity of 81.40% [13]. Thus, similar to
sepsis, DcR3 might turn out to be a novel target of
bacterial meningitis. Further studies are needed to de-
termine the confirmatory role of abnormally high level
of DcR3 in CSF of patients with bacterial meningitis.
As previously published studies [16,17], sTREM-1
was also found significantly increased in patients with
bacterial meningitis in present study. However, thereFigure 2 Receiver operating characteristic (ROC) curve of
bioscore for the diagnosis of bacterial meningitis. The data
is presented with 95% confidence interval (CI). Bioscore: 0.842
(95% CI 0.770–0.914).are some discrepancies between our data and previ-
ously published data. CSF sTREM-1 has a diagnostic
AUC of 0.82, a sensitivity of 73% and a specificity of
77% [16]. Sensitivity of the study by Bishara J and co-
workers is 77.8%, while the specificity is as high as
100% [17]. However, the sensitivity of sTREM-1 in our
study was poorer, only with a sensitivity of 60.00%.
Several potential explanations for these discrepancies
were as follows:The first explanation may be the difference
of enrolled patients. The population enrolled in this study
only included patients with nosocomial bacterial meningi-
tis. The study by Determann RM et al. has 109 patients,
among them 92 patients being diagnosed with bacterial
meningitis, 8 with viral meningitis and 9 healthy donors.
Only patients with community-acquired bacterial men-
ingitis are recruited [16]. Another study by Bishara J
and coworkers has two groups and only has 21patients,
including 9 patients with a positive culture and 12 pa-
tients with a negative culture, which is much less than
that of this study. Moreover, the study doesn’t have the
limit of WBC count [17]. Another important explan-
ation might be technical. Except for the ELISA kits from
different manufacturers, the sensitivity was different,
which might lead to a lower cut- off value of sTREM-1
in present study.
In addition to the individual diagnostic accuracy of
each biomarker, the combination of DcR3 and sTREM-1
into a bioscore appeared to be an efficient and practical
way to discriminate patients with bacterial meningitis
from patients with non-bacterial meningitis. The OR of
biscore was 7.007. The same as other disorders or dis-
eases, such as sepsis and severe malaria [19,22], the
higher the score was recorded, the greater the possibility
of being infected by bacteria was determined. Bioscore 2
could yield 95.65% of patients with bacterial meningitis.
With at least one of the two biomarkers higher than the
critical point (bioscore ≥1), about 86% of patients were
found to be infected by bacteria. Nonetheless, with a
bioscore of 0, 28.89% of patients could not be excluded.
Figure 3 Group of patients according to the bioscore. BM: bacterial meningitis; Non-BM: non-bacterial meningitis. The types of
organisms according to the bioscore are as follows: Bioscore 0, coagulase-negative Staphylococci (n=10), Staphylococcus aureus (n=2) and
Pseudomonas aeruginosa (n=1); Bioscore 1, coagulase-negative Staphylococci (n=18), Staphylococcus aureus (n=1), Pediococcus pentosaceus
(n=1), Klebsiella pneumoniae (n=1), Bacillus typhi suis (n=1), a mix infection of coagulase-negative Staphylococci and Acinetobacter baumannii
(n=1); Bioscore 2, coagulase-negative Staphylococci (n=34), Staphylococcus aureus (n=1), Enterobacter cloacae (n=3), Pseudomonas aeruginosa
(n=1), Klebsiella pneumoniae (n=1), Escherichia coli (n=2), Acinetobacter baumannii (n=1) and Pseudomonas oryzihabitans (n=1).
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not collected, predictive value of combined bioscore in
blood for bacterial meningitis was not determined. Fur-
ther studies are required to validate the potential value
of combined bioscore in serum for the diagnosis of bac-
terial meningitis.
Currently, CSF culture is still the golden standard for
the diagnosis of bacterial meningitis. Early diagnosis of
bacterial meningitis is still a challenging problem for
clinicians. In this study, although the negative predict-
ive value of bioscore 0 was not satisfactory, a strong
positive predictive value was found if the bioscore was
above 1. It seemed likely that the combined bioscore
could strengthen the clinicians’ decisions besides clin-
ical work-up.
Our study had two major limitations. (1) This retro-
spective study included unsatisfactorily sample size and
firm conclusions were not concluded. The selection of
non-consecutive samples might have resulted in a selec-
tion bias. Predictive value of combined DcR3 and
sTREM-1 needs validation in larger-scale prospective
studies. (2) Only bacterial culture was used to determine
the presence of bacterial meningitis. 11%–30% of pa-
tients with bacterial meningitis are with negative results
of bacterial culture [1]. Therefore, some patients with
non-bacterial meningitis might be misclassified and limit
the application of our findings.
Conclusions
In conclusion, this retrospective study demonstrated
that combination of DcR3 and sTREM-1 in CSF couldyielded a better diagnostic value for nosocomial bacter-
ial meningitis than that of each biomarker. Whether the
bioscore be applied routinely in clinic needs further
studies.
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